Predictimmune Revenue and Competitors
Estimated Revenue & Valuation
- Predictimmune's estimated annual revenue is currently $2.8M per year.
- Predictimmune's estimated revenue per employee is $162,000
Employee Data
- Predictimmune has 17 Employees.
- Predictimmune grew their employee count by 13% last year.
Predictimmune's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Product Operations | Reveal Email/Phone |
2 | Executive Director Medical Affairs and Market Access | Reveal Email/Phone |
3 | Product Operations Manager (Principal Scientist) | Reveal Email/Phone |
Predictimmune Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $54.4M | 183 | 6% | N/A | N/A |
#2 | $18M | 74 | -4% | N/A | N/A |
#3 | $162.7M | 482 | 39% | N/A | N/A |
#4 | $42.8M | 144 | 8% | N/A | N/A |
#5 | $26.5M | 98 | 4% | N/A | N/A |
#6 | $33.2M | 123 | -2% | N/A | N/A |
#7 | $29.7M | 110 | 12% | N/A | N/A |
#8 | $15.5M | 66 | -21% | $29.7M | N/A |
#9 | $1645.8M | 4354 | 13% | N/A | N/A |
#10 | $43.7M | 147 | 18% | N/A | N/A |
What Is Predictimmune?
PredictImmune develops pioneering tools for guiding personalised treatment options in immune-mediated diseases such as inflammatory bowel disease (IBD). Based on world-leading research at Cambridge University, UK, we are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payers all recognise the value of such an approach to the management of inflammatory bowel disease (IBD). www.predictimmune.com
keywords:N/AN/A
Total Funding
17
Number of Employees
$2.8M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Predictimmune News
Circulating mitochondrial DNA dynamics in preeclampsia; Cell-free biomarkers to predict immune-related complications of COVID-19,...
... by Cambridge University scientists and produced by company PredictImmune, and said more research was needed before it could be approved.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.5M | 17 | -78% | $305.9M |
#2 | $3.5M | 17 | -6% | N/A |
#3 | $1.5M | 17 | N/A | N/A |
#4 | $1.5M | 17 | 6% | N/A |
#5 | $2.6M | 17 | 0% | N/A |